glp-1 alzheimer's 2025 for Weight Loss and Diabetes High-stakes Novo Nordisk Alzheimer's studies

Global usage patterns: epidemiological context for safety surveillance The prescription and consumption of SSRIs (and other antidepressants) have increased markedly over the past three decades, especially in high-income countries

[DOI] [PMC free article] [PubMed] [Google Scholar] 77.Sanford M

Most patients on compounded GLP-1s should do baseline labs (A1c, fasting glucose, lipids, kidney function, liver function, TSH) before starting and at least once mid-treatment

Emerging agents like tirzepatide and orforglipron demonstrate the expanding horizon of GLP-1-based therapies, offering enhanced efficacy and novel mechanisms of action

[DOI] [PMC free article] [PubMed] [Google Scholar] 82.Abdali D., Samson S.E., Grover A.K

Treatment with empagliflozin significantly decreased mitochondrial area after CA and reduced the expression of Drp1p, a protein that regulates mitochondrial fission